ASSESSMENT OF KNOWLEDGE AND PERCEPTION OF ANTI DOPING AMONG COMMUNITY PHARMACISTS IN BENIN CITY
Faculty
Department
Year of Publication
Publication Type
Abstract
Background: Doping, or the use of performance-enhancing substances, threatens fairness and athlete health worldwide. Pharmacists, as medication experts, are well-positioned to prevent both intentional and inadvertent doping by guiding athletes on safe drug, supplement, and herbal use. However, in Nigeria, pharmacists’ involvement remains limited, with gaps in knowledge, training, and policy integration. Understanding their awareness and perceptions can inform strategies to strengthen their role in promoting clean and ethical sports. Objective: This study evaluates community pharmacists’ knowledge and perceptions of anti-doping practices in Benin City, identifying knowledge gaps and exploring influencing factors. Methods: A cross-sectional study was conducted among 169 registered community pharmacists in Benin City, Nigeria, using convenience sampling. Data were collected via a structured self- administered questionnaire covering demographics, knowledge, perceptions, information sources, and barriers related to anti-doping. Responses were analyzed using descriptive statistics and regression to explore associations and significance. Results: All 169 community pharmacists invited participated in the study. Most were male (65.7%), aged between 26 and 35 years (66.9%), held a BPharm degree (67.5%), and had 1–5 years of work
experience (53.3%). The majority occupied senior roles (92.3%). Their anti-doping knowledge was generally fair (53.3%) or poor (42.6%), with noticeable gaps related to beta-blockers, CPD content, and legal aspects. Overall perceptions of their anti-doping role were strongly positive (75.1%). Longer professional experience and higher qualifications were linked to greater role awareness, though knowledge had only a weak influence on perceptions (p = 0.028, R² = 0.028). Conclusion: Community pharmacists demonstrated fair to poor knowledge of anti-doping, yet they held strongly positive attitudes toward their role in prevention. Significant gaps remain in training, access to resources, and procedural awareness. While more experienced and highly qualified pharmacists recognized their responsibilities better, knowledge had minimal impact on attitudes. Focused CPD, integration of WADA resources, and clear professional guidelines are crucial to fully equip pharmacists for doping prevention.
experience (53.3%). The majority occupied senior roles (92.3%). Their anti-doping knowledge was generally fair (53.3%) or poor (42.6%), with noticeable gaps related to beta-blockers, CPD content, and legal aspects. Overall perceptions of their anti-doping role were strongly positive (75.1%). Longer professional experience and higher qualifications were linked to greater role awareness, though knowledge had only a weak influence on perceptions (p = 0.028, R² = 0.028). Conclusion: Community pharmacists demonstrated fair to poor knowledge of anti-doping, yet they held strongly positive attitudes toward their role in prevention. Significant gaps remain in training, access to resources, and procedural awareness. While more experienced and highly qualified pharmacists recognized their responsibilities better, knowledge had minimal impact on attitudes. Focused CPD, integration of WADA resources, and clear professional guidelines are crucial to fully equip pharmacists for doping prevention.
Supervisor(s)
co-supervisor